Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Gastroenterol., vol
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
When you source blends such as BPC TB from a dedicated research supplier, you gain confidence in labeling and quality control
Always consult a qualified healthcare provider before starting any peptide therapy
US$ 28.39
US$ 23.85
US$ 22.63
US$ 22.97
US$ 23.20
US$ 24.36
